B.R.A.I.N. Biotechnology Research and Information Network (BNN) Stock Statistics & Valuation Metrics

B.R.A.I.N. Biotechnology Research and Information Network has a market cap or net worth of €60.74M. The enterprise value is €75.58.

B.R.A.I.N. Biotechnology Research and Information Network has 21,847,494 shares outstanding. The number of shares has decreased by -2.65% in one year.

B.R.A.I.N. Biotechnology Research and Information Network’s return on equity (ROE) is -6.38 and return on invested capital (ROIC) is -15.93%.

The current PE Ratio of B.R.A.I.N. Biotechnology Research and Information Network is ―. B.R.A.I.N. Biotechnology Research and Information Network’s PEG ratio is -0.69.

In the last 12 months, B.R.A.I.N. Biotechnology Research and Information Network had revenue of 49.62M and earned -11.74M in profits. Earnings per share was -0.54.

In the last 12 months, operating cash flow was -7.44M and capital expenditures -1.55M, giving a free cash flow of -8.99M billion.

B.R.A.I.N. Biotechnology Research and Information Network pays an annual dividend of ―, resulting in a dividend yield of ―

B.R.A.I.N. Biotechnology Research and Information Network upcoming earnings date is Aug 27, 2026, Before Open (Confirmed).

B.R.A.I.N. Biotechnology Research and Information Network as a current ratio of 1.42, with Debt / Equity ratio of -124.42%

In the past 12 months, B.R.A.I.N. Biotechnology Research and Information Network has paid -190.00K in taxes.

B.R.A.I.N. Biotechnology Research and Information Network EV to EBITDA ratio is -15.71, with an EV/FCF ratio of -6.08.

B.R.A.I.N. Biotechnology Research and Information Network has €4.72M in cash and marketable securities with €4.82M in debt, giving a net cash position of -€99.00K billion.

Gross margin is 27.58%, with operating margin of -17.15%, and net profit margin of -23.66%.

The average price target for B.R.A.I.N. Biotechnology Research and Information Network is ―, which is 11.43% higher than the current price. The consensus rating is ―